Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background. Speech changes occur in the early stages of Parkinson’s disease (PD) and cause communication difficulties, leading to social isolation. Lee Silverman voice treatment (LSVT) is a speech therapy approach designed to improve patients’ language and voice capabilities. Objective. The effectiveness of the LSVT was compared with that of other speech interventions or no treatment to evaluate PD patients with dysarthria. Design. Systematic review with meta-analysis of randomized trials. Data Sources: PubMed, Embase, Cochrane Library, CNKI, and SinoMed library were searched from inception to December 2021 related to PD and LSVT. Method. Abstracts were screened and reviewed against the eligibility criteria (intervention group participants were PD assessed based on LSVT (LSVT Loud) and randomized control). Result. Ten randomized controlled trials were identified on speech symptoms in patients with PD. Compared with the respiratory therapy (RET) exercise, or no training group, a significant improvement was detected in the sound press level (SPL) after immediate treatment during the reading of vowel and rainbow passages and an increase in semitone standard deviation (STSD). Furthermore, the LSVT training significantly increased the participants’ scores on unified Parkinson’s disease rating scale (UPDRS-III) and speech intelligibility. Conclusion. This meta-analysis demonstrated the efficacy of LSVT in increasing vocal loudness and functional communication among individuals with PD. However, most studies included participants with mild-moderate PD. Thus, additional randomized controlled trials (RCTs) with large sample sizes are needed to validate the efficacy of LSVT in patients with different progressions of PD, including severe PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“LSVT®LOUD focuses on the voice, specifically aiming to increase vocal amplitude by concentrating on attaining, monitoring, and maintaining a loud voice to counteract hypokinetic dysarthria across the speech mechanism, and uses clinician feedback to recalibrate sensory and motor functions related to vocal loudness [6, 7].”
From Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson’s disease: a pilot randomised controlled trial (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LSVT®LOUD has shown effectiveness in improving voice loudness in reading and spontaneous speech and functional communication in people with PD [6, 8]”
From Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson’s disease: a pilot randomised controlled trial (2025) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“The Lee Silverman Voice Treatment (LSVT®LOUD) is one of the most well-researched, efficacious, and widely used interventions for hypokinetic dysarthria in people with PD [6].”
From Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson’s disease: a pilot randomised controlled trial (2025) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Reeve, A., Simcox, E., & Turnbull, D. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.004 · Cited by 947
Intensive voice treatment (LSVT(R)) for patients with Parkinson's disease: a 2 year follow up
Ramig, L. O. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.493 · Cited by 481 · cited 4×
“3e STSD was described only in three studies (LO Ramig 1995, LO Ramig 1996, LO Ramig 2001a).”
BackgroundMethodInfluentialComparison of Two Forms of Intensive Speech Treatment for Parkinson Disease
Ramig, L. O., Countryman, S., Thompson, L. L., & Horii, Y. (1995) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3806.1232 · Cited by 384
Ramig, L. O., Countryman, S., O'Brien, C., Hoehn, M., & Thompson, L. (1996) · Neurology · doi:10.1212/wnl.47.6.1496 · Cited by 230
Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
Ramig, L., Halpern, A., Spielman, J., Fox, C., & Freeman, K. (2018) · Movement Disorders · doi:10.1002/mds.27460 · Cited by 225 · cited 2×
“Four studies (L O Ramig 2001b, L O Ramig 2018, L O Ramig 1996, Geralyn Schulz 2021) reported that the higher SPL scores during pronunciation vowel, reading of the rainbow passage, and monologues were 8.03 dB (95% CI: 6.25–9.82, P 0.00001), 4.07 dB (95% CI: 2.45–5.69, P 0.00001), and 2.20 dB (95%…”
BackgroundInfluentialEffects of subthalamic stimulation on speech of consecutive patients with Parkinson disease
Tripoliti, E., Zrinzo, L., Martinez-Torres, I., Frost, E., Pinto, S., Foltynie, T., Holl, E., Petersen, E., Roughton, M., Hariz, M. I., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318203e7d0 · Cited by 222
Smith, K. M., & Caplan, D. N. (2018) · Brain and Language · doi:10.1016/j.bandl.2018.08.002 · Cited by 144
Olanow, C. W., Calabresi, P., & Obeso, J. A. (2020) · Movement Disorders · doi:10.1002/mds.28215 · Cited by 113
Aldridge, D., Theodoros, D., Angwin, A. J., & Vogel, A. P. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.09.022 · Cited by 110
Research works printed but not linked: 3
- H. Y. Tang, 2016, Effect of speech therapy with Lee Silverman voice treatment on speech function of Parkinson’s disease patients, Journal of Nursing (China), 23, 66
- W. Qi, 2020, Application effect of stepped speech rehabilitation nursing in patients with Parkinson’s disease, Journal of Anhui health vocational and Technical College, 19, 63
- Y. Meifang, 2017, Lee Silverman voice treatment can improve the speech and the life quality of patients with Parkinson’s disease, Chinese Journal of Physical Medicine Rehabilitation, 39, 43
Cited by
Medical, surgical, and physical treatments for Parkinson's disease
Foltynie, T., Bruno, V., Fox, S., Kühn, A. A., Lindop, F., & Lees, A. J. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01429-0 · Cited by 239
Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial
Troche, M. S., Curtis, J. A., Sevitz, J. S., Dakin, A. E., Perry, S. E., Borders, J. C., Grande, A. A., Mou, Y., Vanegas‐Arroyave, N., & Wheeler‐Hegland, K. (2022) · Movement Disorders · doi:10.1002/mds.29268 · Cited by 68
Favaro, A., Butala, A., Thebaud, T., Villalba, J., Dehak, N., & Moro-Velázquez, L. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00817-9 · Cited by 35
Do We Get What We Need from Clinical Acoustic Voice Measurements?
Brockmann, M., & Soares, M. F. D. P. (2023) · Applied Sciences · doi:10.3390/app13020941 · Cited by 30
Metadata
- Authors
- Pu, T., Huang, M., Kong, X., Wang, M., Chen, X., Feng, X., Wei, C., Weng, X., & Xu, F.
- Affiliations
- Chengdu Medical College (CN)
- Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences (CN)
- Corresponding author
- Weng, Xiechuan
- Xu, Fan
- Venue
- Parkinson's Disease
- Publisher
- Wiley
- Published
- 2021-12-27
- Volume
- 2021
- Pages
- 1-10
- ISSN
- 2042-0080 (ISSN-L)
- 2090-8083
- PMC
- PMC8782619
- OpenAlex
- W4200055663
- Cited by
- 50
- References
- 32
- Citations by year
- 2026: 5 · 2025: 21 · 2024: 16 · 2023: 3 · 2022: 5
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Parkinson s Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Chengdu Medical College (CYZ19-33, 2019-YF09-00097-SN, 20PJ171, S201913705080)
- Chengdu Science and Technology Bureau Focused on Research and Development Support Plan (CYZ19-33, 2019-YF09-00097-SN, 20PJ171, S201913705080)
- Popular Scientific Research Project of Sichuan Health Commission (CYZ19-33, 2019-YF09-00097-SN, 20PJ171, S201913705080)
- Sichuan Undergraduate Innovation and Startup Program Funding Support (CYZ19-33, 2019-YF09-00097-SN, 20PJ171, S201913705080)
- Topics
- Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Health Professions › Speech and Hearing › Dysphagia Assessment and Management
- Keywords
- Lee Silverman Voice Treatment, dysarthria, speech therapy, vocal intensity, speech intelligibility, respiratory care, sound pressure level, UPDRS-III, functional communication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1155/2021/3366870
- The paper
- Pu, T., Huang, M., Kong, X., Wang, M., Chen, X., Feng, X., Wei, C., Weng, X., & Xu, F. (2021). Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis. Parkinson's Disease. https://doi.org/10.1155/2021/3366870
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.